Do Your Legs Feel Heavy, Swollen and Sore?
You could be experiencing the first signs of Chronic Venous Insufficiency. Daflon helps reduce and relieve the following signs and symptoms associated with this progressive condition 1 :
Heavy, Painful or Swollen Legs
Tired Legs
Cramping or Leg pain
Spider or Varicose veins
Looks familiar?
Take our quick self-assessment quiz and use your result to help guide your next steps.
Does Your Bum Itch and Bleed?
You could be experiencing the uncomfortable itching and bleeding caused by Hemorrhoids. Daflon works quickly to reduce and relieve the following signs and symptoms of acute and recurring hemorrhoids 2,3 :
Incomplete evacuation
Bleeding
Itchy bottom
Pain or discomfort
Chronic Venous Insufficiency
Doesn’t have to stop you putting your best feet forward.
Chronic Venous Insufficiency is a progressive condition affecting leg veins and blood circulation. This can lead to blood pooling in the legs, which can be very painful and may even lead to ulcers if left untreated.
Daflon is clinically proven to relieve chronic venous insufficiency symptoms such as legs pain and heaviness. It also protects capillaries and improves microcirculation. Finally It helps prevent disease progression. 1
Hemorrhoids
Don't need to be an uncomfortable fact of life.
Hemorrhoids, or piles, are swellings inside and around your anus as a result of increased pressure on the blood vessels in your bottom, which causes them to stretch and swell, in a similar way to varicose veins.
Daflon is clinically proven to quickly relieve the symptoms of hemorrhoids and reduce the frequency with which episodes recur. 2,3
Browse Our Blogs
To learn more about living with Chronic Venous Insufficiency and Hemorrhoidal disease and how Daflon could help you manage your symptoms.
Safety Information:
Daflon 500mg Safety Information
Daflon 500: Micronized, purified flavonoid fraction 500 mg: 450 mg diosmin; 50 mg flavonoids expressed as hesperidine.
INDICATIONS*
Treatment of the symptoms of chronic venous disease of the lower limbs, either organic or functional: feeling of heavy legs, pain, night cramps. Treatment of acute hemorrhoidal episodes.
DOSAGE AND ADMINISTRATION*
In venous disease: 1000mg daily.In acute hemorrhoidal attacks: the dosage can be increased up to 3000mg daily.
CONTRAINDICATIONS*
Hypersensitivity to the active substance or to any of the excipients.
WARNINGS*
The administration of this product for the symptomatic treatment of acute hemorrhoids does not preclude treatment for other anal conditions. If symptoms do not subside promptly, a proctological examination should be performed and the treatment should be reviewed.
Excipients: sodium-free.
INTERACTION(S)*
FERTILITY* PREGNANCY / LACTATION* - Treatment should be avoided.
DRIVE & USE MACHINES*
UNDESIRABLE EFFECTS*
Common: diarrhoea, dyspepsia, nausea, vomiting. Rare: dizziness, headache, malaise, rash, pruritus, urticaria. Uncommon: colitis. Frequency not known: abdominal pain, isolated face, lip, eyelid oedema. Exceptionally Quincke's oedema.
OVERDOSE PROPERTIES*
Vascular protector and venotonic.
[Tradename] acts on the return vascular system: it reduces venous distensibility and venous stasis; in the microcirculation, it normalizes capillary permeability and reinforces capillary resistance.
PRESENTATION*
LES LABORATOIRES SERVIER, 50 rue Carnot, 92284 Suresnes cedex France. www.servier.com *
For complete information, please refer to the Summary of Product Characteristics for your country.
References:
- Adapted from Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181-254.1
- Shelygin Y, Krivokapic Z, Frolov SA, et al. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease. Curr Med Res Opin. 2016;32(11):1821-1826.
- Godeberge P. Daflon 500mg is significantly more effective than placebo in the treatment of hemorrhoids. Phlebology. 1992;7(suppl 2):61-63.*
